LYVE1 anticorps (AA 20-238)
-
- Antigène Voir toutes LYVE1 Anticorps
- LYVE1 (Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE1))
-
Épitope
- AA 20-238
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp LYVE1 est non-conjugé
-
Application
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Réactivité croisée
- Humain, Souris
- Purification
- Antigen Affinity Purified
- Immunogène
- Recombinant Human Lymphatic vessel endothelial hyaluronic acid receptor 1 protein (20-238AA)
- Isotype
- IgG
- Top Product
- Discover our top product LYVE1 Anticorps primaire
-
-
- Indications d'application
- Recommended dilution: WB:1:500-1:2000, IHC:1:20-1:200,
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Antigène
- LYVE1 (Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE1))
- Autre désignation
- LYVE1 (LYVE1 Produits)
- Synonymes
- anticorps LYVE1, anticorps XLKD1, anticorps CRSBP-1, anticorps HAR, anticorps LYVE-1, anticorps 1200012G08Rik, anticorps Crsbp-1, anticorps Lyve-1, anticorps Xlkd1, anticorps lymphatic vessel endothelial hyaluronic receptor 1a, anticorps lymphatic vessel endothelial hyaluronan receptor 1, anticorps lyve1a, anticorps LYVE1, anticorps Lyve1
- Sujet
-
Background: Ligand-specific transporter trafficking between intracellular organelles (TGN) and the plasma membrane. Plays a role in autocrine regulation of cell growth mediated by growth regulators containing cell surface retention sequence binding (CRS). May act as a hyaluronan (HA) transporter, either mediating its uptake for catabolism within lymphatic endothelial cells themselves, or its transport into the lumen of afferent lymphatic vessels for subsequent re-uptake and degradation in lymph nodes.
Aliases: Cell surface retention sequence-binding protein 1 antibody, CRSBP 1 antibody, CRSBP-1 antibody, CRSBP1 antibody, extracellular link domain containing 1 antibody, extracellular link domain-containing 1 antibody, Extracellular link domain-containing protein 1 antibody, HAR antibody, Hyaluronic acid receptor antibody, Lymphatic endothelium specific hyaluronan receptor antibody, lymphatic vessel endothelial hyaluronan receptor 1 antibody, Lymphatic vessel endothelial hyaluronic acid receptor 1 antibody, LYVE 1 antibody, LYVE-1 antibody, LYVE1 antibody, LYVE1_HUMAN antibody, XLKD1 antibody
- UniProt
- Q9Y5Y7
- Pathways
- Glycosaminoglycan Metabolic Process
-